Cancer News and Research

Latest Cancer News and Research

SRI International researchers to disclose preliminary results of NTD detecting diagnostic at 239th ACS

SRI International, an independent nonprofit research and development organization, will present preliminary results of a diagnostic to detect neglected tropical diseases (NTDs) at the 239th National Meeting & Exhibition of the American Chemical Society (ACS) being held on March 21-25 in San Francisco.

22 Mar 2010

Male infertility linked to increased risk of high grade prostate cancer

Infertile men have an increased risk of developing high grade prostate cancer, which is more likely to grow and spread quickly. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that because infertility may be an identifiable risk factor for prostate cancer, early screening may be warranted in infertile men.

22 Mar 2010

Nanotechnology weapons for cancer

US Researchers have come up with new nanoparticle robots that are essentially a tiny army that can travel in the blood till they reach the cancers and then tweak some important cancer causing genes that can cure the cancer.

22 Mar 2010

Mayo Clinic co-led research finds first gene linked to lung cancer in "never smokers"

A five-center collaborative study that scanned the genomes of thousands of "never smokers" diagnosed with lung cancer as well as healthy never smokers has found a gene they say could be responsible for a significant number of those cancers.

22 Mar 2010

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).

22 Mar 2010

Scientists identify new growth factor that stimulates expansion of hematopoietic stem cells

Scientists at Duke University Medical Center have identified a new growth factor that stimulates the expansion and regeneration of hematopoietic (blood-forming) stem cells in culture and in laboratory animals. The discovery, appearing in the journal Nature Medicine, may help researchers overcome one of the most frustrating barriers to cellular therapy: the fact that stem cells are so few in number and so stubbornly resistant to expansion.

22 Mar 2010

'Dipstick' 3-in-1 test for detection of Chagas' disease, leishmaniasis and African trypanosomiasis

A new simple, inexpensive three-in-one test to diagnose a terrible trio of parasitic diseases that wreak havoc in the developing world is passing preliminary tests, scientists reported here today. Described during the 239th National Meeting of the American Chemical Society the test is for Chagas' disease, leishmaniasis, and "sleeping sickness" or African trypanosomiasis.

22 Mar 2010

Novel ways of killing TB causing bacteria discovered

Researchers at Albert Einstein College of Medicine of Yeshiva University have found two novel ways of killing the bacteria that cause tuberculosis (TB), a disease responsible for an estimated two million deaths each year. The findings, published in the March 21 online issue of Nature Chemical Biology, could lead to a potent TB therapy that would also prevent resistant TB strains from developing.

22 Mar 2010

Aqua Sphere organizes event to raise funds and awareness for breast and prostate cancer

Aqua Sphere, the leader in high-end, innovative swim products, dares to see who will go the distance -- men or women?

20 Mar 2010

AAHRPP re-accredits BRI

Officials announced today that Baylor Research Institute (BRI), part of the Baylor Health Care System, was recently re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The re-accreditation certifies that BRI maintains efficient systems for monitoring research participant safety and embraces ethical standards higher than required by law in order to protect human participants participating in BRI research programs. Only 200 out of the thousands of human research protection programs in the U.S., Canada and abroad have earned this prestigious distinction.

20 Mar 2010

Penny-wise and pound-foolish: Proposal to eliminate funding for New Jersey's tobacco prevention program

Governor Christie has let down New Jersey's kids and taxpayers with his proposal to eliminate funding for New Jersey's tobacco prevention and cessation program. This proposal will lead to more kids becoming addicted to tobacco, fewer tobacco users getting the help they need to quit, more lives being lost and New Jersey taxpayers paying the bill for higher tobacco-caused health care costs. It is truly penny-wise and pound-foolish budgeting.

20 Mar 2010

HHS awards more than $372M to 44 communities to support public health efforts

The U.S. Department of Health and Human Services today announced awards of more than $372 million to 44 communities, to support public health efforts to reduce obesity and smoking, increase physical activity and improve nutrition.

20 Mar 2010

Akela Pharma files restated Management Discussion and Analysis for 2008 fiscal year

Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today that it has today filed a restated Management Discussion and Analysis ("MD&A) for the fiscal year ended 2008.

20 Mar 2010

Dartmouth-Hitchcock Medical Center awarded ECRI Institute Health Devices Achievement Award

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, is pleased to report that Dartmouth-Hitchcock Medical Center (Lebanon, New Hampshire) has received the 4th Annual ECRI Institute Health Devices Achievement Award yesterday for an innovative patient monitoring project that uses its Masimo SET pulse oximetry and Masimo Patient SafetyNet remote monitoring and clinician notification system.

20 Mar 2010

EUREKA project develops unique range of antibodies

EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies - the proteins produced in the blood which counteract bacteria, viruses or cancerous cells.

20 Mar 2010

Turning microRNAs into novel drugs

Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News (GEN). These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.

20 Mar 2010

Breast cancer survivors at increased risk of developing second cancer: Study

Certain rare mutations in the ataxia telangiectasia mutated gene, combined with radiation exposure, may increase a woman's risk of developing a second cancer in the opposite breast, according to a study published online March 19 in the Journal of the National Cancer Institute.

20 Mar 2010

Winner of 2010 European Magnetic Resonance Award

Dr John Griffiths, a Cancer Research UK-funded scientist, has received the 2010 European Magnetic Resonance Award for Basic Sciences.

20 Mar 2010

DARA BioSciences receives NASDAQ non-compliance notice

On March 16, 2010, DARA BioSciences, Inc. received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company had not timely regained compliance with the $1.00 bid price requirement, as set forth in Listing Rule 5550(a)(2). DARA plans to timely request a hearing before a NASDAQ Listing Qualifications Panel, at which it will request the continued listing of its securities on The NASDAQ Capital Market pending the completion of its plan to evidence compliance with the minimum bid price requirement.

20 Mar 2010

Susan G. Komen receives $31,680 as donation for the Cure, San Diego

The Associates of AimLoan.com, a San Diego based Internet Direct Lender, announced a generous donation to Susan G. Komen for the Cure, San Diego for a total of $31,680. This contribution positions the organization as the second largest corporate donor in San Diego. The donation is a result of their 4th Quarter 2009 Community Service Website Campaign.

20 Mar 2010

Cancer News and Research

Latest Cancer News and Research

SRI International researchers to disclose preliminary results of NTD detecting diagnostic at 239th ACS

Male infertility linked to increased risk of high grade prostate cancer

Nanotechnology weapons for cancer

Mayo Clinic co-led research finds first gene linked to lung cancer in "never smokers"

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

Scientists identify new growth factor that stimulates expansion of hematopoietic stem cells

'Dipstick' 3-in-1 test for detection of Chagas' disease, leishmaniasis and African trypanosomiasis

Novel ways of killing TB causing bacteria discovered

Aqua Sphere organizes event to raise funds and awareness for breast and prostate cancer

AAHRPP re-accredits BRI

Penny-wise and pound-foolish: Proposal to eliminate funding for New Jersey's tobacco prevention program

HHS awards more than $372M to 44 communities to support public health efforts

Akela Pharma files restated Management Discussion and Analysis for 2008 fiscal year

Dartmouth-Hitchcock Medical Center awarded ECRI Institute Health Devices Achievement Award

EUREKA project develops unique range of antibodies

Turning microRNAs into novel drugs

Breast cancer survivors at increased risk of developing second cancer: Study

Winner of 2010 European Magnetic Resonance Award

DARA BioSciences receives NASDAQ non-compliance notice

Susan G. Komen receives $31,680 as donation for the Cure, San Diego

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in